Search research articles
Contact Us
Filters
Showing results (411-420 of 488) with videos related to
Page
of 49
Sort By:
Arthritis Research & Therapy
|
August 22, 2012
Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice
Ajay Jain, Henrik S Olsen, Ravi Vyzasatya, et al.
Annals of the Rheumatic Diseases
|
April 15, 2004
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
S B Cohen, L W Moreland, J J Cush, et al.
Melanoma Research
|
August 29, 2024
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting
Ronen Stoff, Svetomir N Markovic, Robert R McWilliams, et al.
Oncoimmunology
|
June 12, 2020
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer
Yingxue Ren, Yesesri Cherukuri, Daniel P Wickland, et al.
Gynecologic Oncology
|
May 3, 2017
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers
Gerardo Colon-Otero, S John Weroha, Nathan R Foster, et al.
JCO Clinical Cancer Informatics
|
April 30, 2024
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing
Hannah Barman, Sriram Venkateswaran, Antonio Del Santo, et al.
Journal of Autoimmunity
|
August 24, 2017
Recombinant human IgG1 based Fc multimers, with limited FcR binding capacity, can effectively inhibit complement-mediated disease
Haoping Sun, Henrik S Olsen, Emmanuel Y Mérigeon, et al.
Oncogene
|
August 7, 2023
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
Upasana Ray, Prabhu Thirusangu, Ling Jin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 2, 2024
MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use
Stephanie B Syc-Mazurek, Hannah Zhao-Fleming, Yong Guo, et al.
The International Journal of Oral & Maxillofacial Implants
|
August 17, 2002
Prospective evaluation of implants connected to teeth
Michael S Block, Denise Lirette, Diana Gardiner, et al.
Page
of 49
Search research articles
Search
Showing results (411-420 of 488) with videos related to
Sort By:
Page
of 49
Arthritis Research & Therapy
|
August 22, 2012
Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice
Ajay Jain, Henrik S Olsen, Ravi Vyzasatya, et al.
Annals of the Rheumatic Diseases
|
April 15, 2004
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
S B Cohen, L W Moreland, J J Cush, et al.
Melanoma Research
|
August 29, 2024
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting
Ronen Stoff, Svetomir N Markovic, Robert R McWilliams, et al.
Oncoimmunology
|
June 12, 2020
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer
Yingxue Ren, Yesesri Cherukuri, Daniel P Wickland, et al.
Gynecologic Oncology
|
May 3, 2017
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers
Gerardo Colon-Otero, S John Weroha, Nathan R Foster, et al.
JCO Clinical Cancer Informatics
|
April 30, 2024
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing
Hannah Barman, Sriram Venkateswaran, Antonio Del Santo, et al.
Journal of Autoimmunity
|
August 24, 2017
Recombinant human IgG1 based Fc multimers, with limited FcR binding capacity, can effectively inhibit complement-mediated disease
Haoping Sun, Henrik S Olsen, Emmanuel Y Mérigeon, et al.
Oncogene
|
August 7, 2023
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
Upasana Ray, Prabhu Thirusangu, Ling Jin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 2, 2024
MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use
Stephanie B Syc-Mazurek, Hannah Zhao-Fleming, Yong Guo, et al.
The International Journal of Oral & Maxillofacial Implants
|
August 17, 2002
Prospective evaluation of implants connected to teeth
Michael S Block, Denise Lirette, Diana Gardiner, et al.
Page
of 49